These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 4425844)

  • 21. Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.
    Cammas B; Harambat J; Bertholet-Thomas A; Bouissou F; Morin D; Guigonis V; Bendeddouche S; Afroukh-Hacini N; Cochat P; Llanas B; Decramer S; Ranchin B
    Nephrol Dial Transplant; 2011 Jan; 26(1):178-84. PubMed ID: 20610527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term prognosis of the nephrotic syndrome in childhood.
    Schärer K; Minges U
    Clin Nephrol; 1973; 1(3):182-7. PubMed ID: 4783717
    [No Abstract]   [Full Text] [Related]  

  • 23. Steroid-dependent nephrotic syndrome in children: histopathology and relapses after cyclophosphamide treatment.
    Siegel NJ; Gaudio KM; Krassner LS; McDonald BM; Anderson FP; Kashgarian M
    Kidney Int; 1981 Mar; 19(3):454-9. PubMed ID: 7241883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclophosphamide in the treatment of glomerulonephritis.
    Ibels LS; Palmer AA; Mahony JF; Stewart JH
    Prog Biochem Pharmacol; 1974; 9():65-81. PubMed ID: 4438383
    [No Abstract]   [Full Text] [Related]  

  • 25. Gonadal function in women treated with cyclophosphamide for childhood nephrotic syndrome: a long-term follow-up study.
    Watson AR; Taylor J; Rance CP; Bain J
    Fertil Steril; 1986 Aug; 46(2):331-3. PubMed ID: 3732541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cyclophosphamide in idiopathic nephrotic syndrome: Outcome and outlook].
    Berkane M; Adarmouch L; Amine M; Bourrahouat A; Ait Sab I; Sbihi M
    Nephrol Ther; 2018 Apr; 14(2):85-90. PubMed ID: 29631702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proceedings: Long-term stability of remission in the nephrotic syndrome after treatment with cyclophosphamide.
    Chantler C; Cameron JS; White RH; Ogg CS
    Arch Dis Child; 1974 Oct; 49(10):823. PubMed ID: 4429383
    [No Abstract]   [Full Text] [Related]  

  • 28. The nephrotic syndrome in adults with 'minimal change' glomerular lesions.
    Cameron JS; Turner DR; Ogg CS; Sharpstone P; Brown CB
    Q J Med; 1974 Jul; 43(171):461-88. PubMed ID: 4422336
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of nephrotic syndrome in childhood.
    Melvin T; Bennett W
    Drugs; 1991 Jul; 42(1):30-51. PubMed ID: 1718684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrence of nephrotic syndrome after renal transplantation: influence of increased immunosuppression.
    Nathanson S; Cochat P; André JL; Guyot C; Loirat C; Nivet H; Deschênes G
    Pediatr Nephrol; 2005 Dec; 20(12):1801-4. PubMed ID: 16228184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Familial nephrotic syndrome].
    Mehls O; Schärer K
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):328-30. PubMed ID: 5523675
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Arch Dis Child; 1987 Nov; 62(11):1102-6. PubMed ID: 3688915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlorambucil treatment of frequently relapsing nephrotic syndrome.
    Grupe WE; Makker SP; Ingelfinger JR
    N Engl J Med; 1976 Sep; 295(14):746-9. PubMed ID: 958261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulse cyclophosphamide therapy in frequently relapsing nephrotic syndrome.
    Gulati S; Pokhariyal S; Sharma RK; Elhence R; Kher V; Pandey CM; Gupta A
    Nephrol Dial Transplant; 2001 Oct; 16(10):2013-7. PubMed ID: 11572890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome.
    Webb H; Jaureguiberry G; Dufek S; Tullus K; Bockenhauer D
    Pediatr Nephrol; 2016 Apr; 31(4):589-94. PubMed ID: 26525199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with cyclophosphamide in elderly-onset nephrotic syndrome.
    Mak SK; Lo KY; Wong CY; Tong GM; Wong PN; Wong AK
    Nephron Clin Pract; 2005; 101(1):c25-32. PubMed ID: 15886494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid-responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth.
    Berns JS; Gaudio KM; Krassner LS; Anderson FP; Durante D; McDonald BM; Siegel NJ
    Am J Kidney Dis; 1987 Feb; 9(2):108-14. PubMed ID: 3826059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cyclosporin A versus cyclophosphamide in the treatment of nephrotic syndrome in children].
    Podracká L; Böör A; Sasinka M
    Cas Lek Cesk; 2008; 147(1):38-43. PubMed ID: 18323041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimal-lesion nephrotic syndrome with early resistance to steroid therapy.
    Siegel NJ; Gur A; Krassner LS; Kashgarian M
    J Pediatr; 1975 Sep; 87(3):377-80. PubMed ID: 1165516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adult-onset nephrotic syndrome with minimal changes: response to corticosteroids and cyclophosphamide.
    Nolasco F; Cameron JS; Hicks J; Ogg CS; Williams DG
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():588-93. PubMed ID: 3991549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.